GeneralConnection.com ➔ Dictionary
Dictionary Search

melphalan

Synonyms

Noun

1. Alkeran

2. antineoplastic, antineoplastic drug, cancer drug

Usage
Flare of clonal hematopoiesis, TP53 expansion and prior melphalan drive post-CAR-T myeloid disorders in multiple myeloma - Nature
Melphalan/Hepatic Delivery System Displays Efficacy in Uveal Melanoma - CancerNetwork
Melphalan/HDS Shows Favorable Results in Patients with Low Hepatic Tumor Burden - Targeted Oncology
Outcomes of fludarabine-melphalan versus fludarabine-busulfan reduced-intensity conditioning regimens for allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies: A systematic review and meta-analysis - Wiley
Melphalan-Based Myeloablation May Be a Viable Option for Advanced Pediatric MDS - Hematology Advisor
Is Less “Sufficient” and “Safe” in the MRD Era - Outcomes of Autologous Stem-Cell Transplant as per Melphalan Dose in Patients with Multiple Myeloma | Blood Cancer Journal - Nature
Delcath Systems, Inc. Announces Inclusion of CHEMOSAT Hepatic Delivery System for Melphalan as a Recommended Liver-Directed Regional Therapy Option in the ESMO–EURACAN Clinical Practice Guidelines for Uveal Melanoma - Yahoo Finance
How Does Melphalan Treat Uveal Melanoma That Spreads to the Liver? - City of Hope
Multiple myeloma after CAR T: TP53-mutant clonal hematopoiesis flags early AML and MDS risk - Vera Health
Can the Melphalan Rest Day Before Stem Cell Infusion Be Safely Eliminated? - Cancer Nursing Today
Induction therapy with bortezomib, melphalan, and prednisone followed by lenalidomide and dexamethasone versus carfilzomib, lenalidomide, and dexamethasone with or without daratumumab in older, fit patients with newly diagnosed multiple myeloma (GE - The Lancet
Updated EHA-EMN Guidelines Include Melphalan Flufenamide for R/R Myeloma - OncLive
Thalidomide as a rescue protocol for treatment of multiple myeloma in dogs: preliminary data from a multicentre retrospective study - Frontiers
Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma - The New England Journal of Medicine
Melphalan 140 mg/m2 or 200 mg/m2 for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic Malignancies Working Party - Haematologica
Intra-arterial Melphalan as Targeted Therapy for Tumefactive Multiple Sclerosis Lesions - Neurology® Journals
Delcath Systems Announces Presentation of New Data on Percutaneous Hepatic Perfusion with Melphalan in Liver-Dominant Metastatic Breast Cancer at ESMO Breast Cancer 2026 - Yahoo Finance
Long-term survival outcomes of allo-HCT in AML with fludarabine/melphalan conditioning and tacrolimus/sirolimus GVHD prophylaxis | Bone Marrow Transplantation - Nature
Ice-cream used as cryotherapy during high-dose melphalan conditioning reduces oral mucositis after autologous hematopoietic stem cell transplantation - Nature
Melphalan-based conditioning with post-transplant cyclophosphamide for peripheral blood stem cell transplantation: donor effect | Bone Marrow Transplantation - Nature
Fludarabine melphalan reduced intensity conditioning vs radiation-based myeloablative conditioning in patients undergoing allogeneic transplantation for acute myeloid leukemia with measurable residual disease - Nature
Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients – A clinical trial to registry data comparison | Bone Marrow Transplantation - Nature
Outcomes of attenuated dose fludarabine and melphalan based conditioning regimen in patients undergoing allogeneic stem cell transplant: a propensity score-matched analysis | Bone Marrow Transplantation - Nature
Curcumin and melphalan cotreatment induces cell cycle arrest and apoptosis in MDA-MB-231 breast cancer cells - Nature
FDA Withdraws Melphalan Flufenamide Approval Status in Multiple Myeloma - CancerNetwork
Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma - The New England Journal of Medicine
High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis - The New England Journal of Medicine
Comparison of fludarabine/melphalan (FM140) with fludarabine/melphalan/BCNU (FBM110) in patients with relapsed/refractory AML undergoing allogeneic hematopoietic cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working P - Nature
The mutagenic impact of melphalan in multiple myeloma - Nature
Delcath Systems Announces Investigator-Initiated CHOPIN Phase 2 Trial Presentation at ESMO 2025 Congress - BioSpace
In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT | Bone M - Nature
Cytotoxic efficacy of filanesib and melphalan combination is governed by sequence of treatment in human myeloma cells - Nature
Navigating hair loss, and regrowth, after SCT for multiple myeloma - Rare Cancer News
European Commission Approves Melphalan Flufenamide for Relapsed/Refractory Multiple Myeloma - OncLive
FDA Confirms Decision to Withdraw Melphalan Flufenamide Approval in Multiple Myeloma - OncLive
Adding bendamustine to melphalan before ASCT improves CR rate in myeloma vs. melphalan alone: A randomized phase-2 trial - Nature
High-dose thiotepa, in conjunction with melphalan, followed by autologous hematopoietic stem cell transplantation in patients with pediatric solid tumors, including brain tumors - Nature
Apotex introduces IVRA™ (Melphalan) hydrochloride injection: First ready to dilute liquid formulation of Melphalan injection approved via 505(b)(2) NDA in the United States - PR Newswire
What is the best first-line treatment for POEMS syndrome: autologous transplantation, melphalan and dexamethasone, or lenalidomide and dexamethasone? - Nature
Low-Dose Melphalan Achieves Survival Outcomes, Relapse Rates Similar to Standard Dose - Oncology Nurse Advisor
Melphalan/HDS Shows Benefit in Metastatic Uveal Melanoma - Targeted Oncology
Comparative analysis of reduced toxicity conditioning regimens between fludarabine plus melphalan and fludarabine plus busulfex in adult patients with acute lymphoblastic leukemia | Bone Marrow Transplantation - Nature
A higher throughput assay for quantification of melphalan-induced DNA damage in peripheral blood mononuclear cells - Nature
FDA Approves New Melphalan Formulation in Myeloma - OncLive
Olanzapine versus Fosaprepitant for Chemotherapy-Induced Nausea and Vomiting Prophylaxis in Patients Receiving Single-Day High-Dose Melphalan - Journal of Hematology Oncology Pharmacy
Lc-ms/ms Quantification Of Melphalan Plasma Levels In Children Undergoing Selective Intra-arterial Infusion Of Chemotherapy For Retinoblastoma | IOVS | ARVO Journals - ARVO Journals
VisualAbstract Melphalan 200mg/m2 Versus Reduced Doses of Melphalan in Multiple Myeloma Patients Receiving Autologous Stem Cell Transplantation - 2 Minute Medicine
Comparison of fludarabine, a myeloablative dose of busulfan, and melphalan vs conventional myeloablative conditioning regimen in patients with relapse and refractory acute myeloid leukemia in non-remission status - Nature
ODAC Gives Negative Opinion of Melphalan Flufenamide (Pepaxto) - Oncology News Central
Microbiota dysbiosis after high-dose melphalan and autologous hematopoietic cell transplantation in multiple myeloma - Nature
Comparison of fludarabine–melphalan and fludarabine–treosulfan as conditioning prior to allogeneic hematopoietic cell transplantation—a registry study on behalf of the EBMT Acute Leukemia Working Party - Nature
Comparison of reduced-toxicity conditioning protocols using fludarabine, melphalan combined with thiotepa or carmustine in allogeneic hematopoietic cell transplantation - Nature
Transplant conditioning with bortezomib, thalidomide, and melphalan and intensive 2 year post-transplant therapy for multiple myeloma in older patients - Nature
Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma - The New England Journal of Medicine
High-dose melphalan-autologous hematopoietic cell transplantation in systemic AL amyloidosis following daratumumab-based frontline therapy - Nature
Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02 - The Lancet
Jonathan S. Zager, MD, Reviews Percutaneous Hepatic Perfusion With Melphalan in Ocular Melanoma With Hepatic Metastases - CancerNetwork
FDA Revokes Melphalan Flufenamide Approval, Citing Efficacy/Safety Concerns - Targeted Oncology
Autologous Transplantation and Maintenance Therapy in Multiple Myeloma - The New England Journal of Medicine
High-Dose Melphalan Conditioning Benefits Patients With Multiple Myeloma - Physician's Weekly
Neuralgic amyotrophy following high-dose melphalan and autologous peripheral blood stem cell transplantation for AL amyloidosis - Nature
Generic melphalan available in US - MDEdge
Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Par - Nature
A second course of high-dose melphalan and auto-SCT for the treatment of relapsed AL amyloidosis - Nature
An elective single autograft with high-dose melphalan: single-center study of 451 patients - Nature
A Trial of Three Regimens for Primary Amyloidosis: Colchicine Alone, Melphalan and Prednisone, and Melphalan, Prednisone, and Colchicine - The New England Journal of Medicine
FDA OKs First Liver-Directed Treatment for Metastatic Uveal Melanoma - MedPage Today
High-dose chemotherapy and autologous stem cell transplantation with melphalan, etoposide and carboplatin for high-risk osteosarcoma - Nature
Case Report: Response to Regional Melphalan via Limb Infusion and Systemic PD1 Blockade in Recurrent Myxofibrosarcoma: A Report of 2 Cases - Frontiers
Organ responses after highdose melphalan and stemcell transplantation in AL amyloidosis - Nature
A Single Surviving Myeloma Cell Can Seed Accelerated Relapse - Memorial Sloan Kettering Cancer Center
A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation - Nature
Role of isolated limb perfusion with recombinant human tumor necrosis factor α and melphalan in locally advanced extremity soft tissue sarcoma - Wiley
The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma - Nature
Intravitreal Chemotherapy for Retinoblastoma: Promising but Controversial - American Academy of Ophthalmology
Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: incidence, risk factors and a severity predictive model - Nature
Patrick Hwu highlights 2025 study by Jonathan Zager on Melphalan hepatic perfusion for metastatic uveal melanoma - Oncodaily
Day Of Rest Between Melphalan And Stem Cell Infusion May Not Be Necessary For Myeloma Patients - The Myeloma Beacon
PEPAXTO® (melphalan flufenamide) for the Treatment of Multiple Myeloma - Clinical Trials Arena
Early blast clearance during sequential conditioning prior to allogeneic stem cell transplantation in patients with acute myeloid leukaemia - Wiley Online Library
New liver directed treatment improves outcomes for rare eye cancer - News-Medical
Fludarabine phosphate and melphalan: a reduced intensity conditioning regimen suitable for allogeneic transplantation that maintains the graft versus malignancy effect - Nature
Melphalan induced germ cell toxicity and dose-dependent effects of β-aminoisobutyric acid in experimental rat model: Role of oxidative stress, inflammation and apoptosis - Wiley Online Library
Busulfan and cyclophosphamide for autologous stem cell transplantation in patients with multiple myeloma after proteasome inhibitor and/or immunomodulatory drug treatment - Nature
Addition of Daratumumab to Treatment Regimen in Transplant-Ineligible Newly Diagnosed Multiple Myeloma - The ASCO Post
High-dose melphalan and auto-SCT in patients with monoclonal Ig deposition disease - Nature
Melphalan boosts survival in TP53-mutated myeloid neoplasms - the limbic
Novel Drug Device Combination May Improve Outcomes in Metastatic Uveal Melanoma - The ASCO Post
The association of mobilising regimen on immune reconstitution and survival in myeloma patients treated with bortezomib, cyclophosphamide and dexamethasone induction followed by a melphalan autograft - Nature
Risk-adjusted manipulation of melphalan dose before stem cell transplantation in patients with amyloidosis is associated with a lower response rate - Nature
Autologous stem cell transplantation is safe and effective for fit, older myeloma patients - Haematologica
Pre-transplant regimen for autologous SCT in AML patients in CR1 – Busulfan and melphalan or busulfan and cyclophosphamide - aml-hub.com
Thalidomide and Hematopoietic-Cell Transplantation for Multiple Myeloma - The New England Journal of Medicine
Second Primary Malignancies Explored in Multiple Myeloma - The ASCO Post
Long-term outcomes in patients with relapsed/refractory acute myeloid leukemia and other high-risk myeloid malignancies after undergoing sequential conditioning regimen based on IDA-FLAG and high-dose melphalan - Nature
The combination of bortezomib, melphalan, dexamethasone and intermittent thalidomide is an effective regimen for relapsed/refractory myeloma and is associated with improvement of abnormal bone metabolism and angiogenesis - Nature
High-dose melphalan followed by radical radiotherapy for the treatment of massive plasmacytoma of the chest wall - Nature
Delcath’s Hepzato Kit offers better disease control than immunotherapy - Clinical Trials Arena
Hematopoietic stem cell mobilization with intravenous melphalan and G-CSF in patients with chemoresponsive multiple myeloma: report of a phase II trial - Nature
Accelerated Removal: FDA making use of new authority to withdraw ineffective drugs more quickly - AgencyIQ by POLITICO
Foreign Language Equivalents
Foreign Language Equivalents of 'melphalan'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
melphaln,   emlphalan,   melphalam,   melphalsn,   melpahlan,   mephalan,   me;phalan,   mellphalan,   elphalan,   melhalan,   melphallan,   meplhalan,   melphalab,   nelphalan,   melpgalan,   mmelphalan,   melphslan,   melphaan,   melphala,   melohalan,   mlephalan,   meelphalan,   mel[halan,   melhpalan,   mekphalan,   melphhalan,   melphalaan,   mrlphalan,   melphlaan,   melphaaln,   melpalan,   melpphalan,   ,elphalan,   melphakan,   melpjalan,   mwlphalan,   melpha;an,   melphlan,   melphalann,   mlphalan,   melphaalan,   melphalna
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z